Evidence map›Paper›PMID 20716669›Full record

ReviewPharmacological reviews2010

Glutamate receptor ion channels: structure, regulation, and function.

Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Pharmacological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1,890 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,890citing papers in PubMed, 3 pooled it
61.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,890 citing papers in PubMed, 3 syntheses or guidelines pooled it, 3,487 citations in OpenAlex.

  1. Ketamine and other NMDA receptor antagonists for chronic pain.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Differential and state-dependent effects of the GluN2A-selective positive allosteric modulator GNE-5729 on executive functions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,830 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Stephen F TraynelisDepartment of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, GA 30322-3090, USA. strayne@emory.edu
Lonnie P Wollmuth
Chris J McBain
Frank S Menniti
Katie M Vance
Kevin K Ogden
Kasper B Hansen
Hongjie Yuan
Scott J Myers
Ray Dingledine
Emory University · USStony Brook University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

Cellular And Synaptic Physiology Of Hippocampal InterneuronsZIAHD001205 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MCBAIN, CHRIS J. · 2009 to 2025
$45.8M
Graduate and Postdoctoral Training in ToxicologyT32ES012870 · NIEHS · EMORY UNIVERSITY · PI Carmen Joseph Marsit · 2004 to 2026
$9.1M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Control of Glutamate Receptor FunctionR01NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 1998 to 2018
$3.7M
Mechanism of Action of Novel Subunit-Selective NMDA Receptor ModulatorsR01NS065371 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2009 to 2018
$3.4M
Functional Architecture of Glutamate Receptor ChannelsR01MH066892 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI WOLLMUTH, LONNIE P · 2003 to 2012
$3.0M
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTIONR01NS036604 · NINDS · EMORY UNIVERSITY · PI DINGLEDINE, RAYMOND J · 1998 to 2008
$3.0M
Control of glutamate receptor functionR37NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2007 to 2013
$2.4M
Control of AMPA receptor function by phosphorylationR01NS068464 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2010 to 2013
$1.3M
Molecular Properties of Synapses in the Visual CortexR01EY016979 · NEI · STATE UNIVERSITY NEW YORK STONY BROOK · PI WOLLMUTH, LONNIE P · 2005 to 2008
$1.2M
NEI NIH HHS EY01697905NEI NIH HHS R01 EY016979NIDA NIH HHS T32-DA01504006NIEHS NIH HHS T32 ES012870NIEHS NIH HHS T32-ES012870NIGMS NIH HHS T32 GM008602NIGMS NIH HHS T32-GM008602NIMH NIH HHS MH066892NIMH NIH HHS R01 MH066892NINDS NIH HHS NS036604NINDS NIH HHS NS036654NINDS NIH HHS NS065371NINDS NIH HHS NS068464NINDS NIH HHS R01 NS036604NINDS NIH HHS R01 NS036654NINDS NIH HHS R01 NS065371NINDS NIH HHS R01 NS068464NINDS NIH HHS R37 NS036654
6 · The paper itself

Abstract

The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels containing an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore. Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells. These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system. Glutamate receptors are postulated to play important roles in numerous neurological diseases and have attracted intense scrutiny. The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel. In this review we discuss International Union of Basic and Clinical Pharmacology glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacology, allosteric modulation, mechanisms of gating and permeation, roles in normal physiological function, as well as the potential therapeutic use of pharmacological agents acting at glutamate receptors.

Indexed as

Gene ExpressionHumansIon ChannelsProtein Processing, Post-TranslationalProtein SubunitsReceptors, GlutamateSynaptic TransmissionTerminology as TopicIon ChannelsProtein SubunitsReceptors, Glutamate

Identifiers

PMID20716669
PMCPMC2964903
OpenAlexW2037852973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.